State implementation of the AIDS drug assistance programs.
Acquired immunodeficiency syndrome (AIDS) drug assistance programs (ADAPs) provide access to medications for people who lack other health coverage. In this article, the authors present the results of a 1997 survey identifying how 48 States implemented ADAPs, focusing on the number of beneficiaries, medical and financial eligibility criteria, the administration of waiting lists, and the coverage of drugs including protease inhibitors. Increased funding for ADAPs is necessary to maintain this important part of the public sector safety net for human immunodeficiency virus (HIV) care.
Buchanan
R J
RJ
Medical University of South Carolina, USA.
Smith
S R
SR
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000191:economics*; D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D004608:Eligibility Determination; D005569:Formularies as Topic; D017320:HIV Protease Inhibitors / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D019458:Insurance Coverage; D008483:Medical Assistance / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D017057:Medically Uninsured; D015397:Program Evaluation / Q000706:statistics & numerical data*; D013221:State Health Plans; D014481:United States; D014850:Waiting Lists
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors